Pivotal AARA Clinical Research on Non-Medicine RA Treatment Published in Nature Medicine
Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial
Recognition for the research study that led to the FDA-approval of a vagal nerve stimulator for adults with moderate to severe rheumatoid arthritis (RA) continues to gain traction in the medical community. Nature Medicine, a premiere research journal, published the work of Principal Investigator John R.P. Tesser, MD, FACP, MACR, and key contributor AARA Clinical Research—work that now gives patients a new treatment option for RA, particularly those resistant to traditional medical treatments.
"As we know, this is the first device to be approved by the FDA for any autoimmune disease and specifically for rheumatoid arthritis. And this is the first new mechanism of action treatment approved for rheumatoid arthritis since 2012!"
John R. P. Tesser, MD, FACP, FACR, MACR
